Combining CAR-T cells and inhibitor drugs for high-risk neuroblastoma
Roberto Chiarle, MD, at Boston Children's Hospital and his colleagues now report a way to make CAR-T cell therapy work better in neuroblastoma. They hope to begin testing it soon in children at high risk.